Posted 07 February 2013 - 03:05 AM
Posted 07 February 2013 - 06:05 AM
Posted 07 February 2013 - 08:14 AM
There is a very nice editorial in Science by Francis Collins on this topic: http://www.sciencema...7/6094/503.full
With regard to the TM hyper, he said:
Posted 09 February 2013 - 05:07 AM
Posted 11 February 2013 - 11:34 AM
I don't know where you live, but if you're interested in European "research landscapes", there's this free magazine Lab Times which sometimes publishes analyses on funding and grants policies in different countries and similar stuff. Maybe you could search the online archive.
Edited by Tabaluga, 11 February 2013 - 11:37 AM.
Posted 26 February 2013 - 04:04 AM
However we now have a brand new shiny huge translation medicine institute just across the street, and they have everything, NGS, animal facilities, drug screenng robots, core labs and other things I forgot, to study cancers mostly and identify new drug targets and already produce a substance that is not only potential drug, because pharma companies are not that interested in such, but doing already the first rounds of functional trials. The plan is that in that case pharma companies would be much more interested in investment and further developement. I think this is a bold plan but they have all that is needed (except for people, a bit) and they have chance to succeed.
And they have to, because the initial EU funding will dry out in few years and they have to make money to maintain all this. It's such a huge project that it will either be a massive success in local measures or it will sink down the whole university if it fails.
I never trust anything that can't be doubted.
Also tagged with one or more of these keywords: funding, translational medicine, pharma, biotech, grants
Sit Back and Relax →
Lab Home Pages and Useful Life Science Websites →
Protocols and Techniques Forums →
Molecular Biology →